Olema Pharmaceuticals Q2 EPS $(0.61) Misses $(0.55) Estimate
Benzinga Newsdesk 2 months ago
NewsEarningsEarnings Misses
Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.55) by 10.91 percent. This is a 19.61 percent decrease over losses of $(0.51) per
Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.55) by 10.91 percent. This is a 19.61 percent decrease over losses of $(0.51) per share from the same period last year.